Summary
This joint clinical practice guideline from major United States cardiovascular organisations synthesises contemporary evidence for managing chronic coronary disease across multiple domains including risk factor modification. Whilst the guideline's primary focus is clinical management and pharmacotherapy rather than detailed nutritional mechanistics, it incorporates evidence-based dietary recommendations as part of comprehensive secondary prevention strategy. The document represents authoritative consensus guidance intended for healthcare practitioners managing patients with established coronary disease.
Regional applicability
This is a United States-authored clinical guideline. Its direct applicability to United Kingdom cardiovascular practice may be limited, as the UK follows NICE and British Cardiovascular Society guidance adapted to NHS contexts; however, underlying evidence base and therapeutic principles are likely to have international relevance to coronary disease management.
Key measures
Clinical practice recommendations, risk factor management strategies, dietary and lifestyle intervention guidance for coronary disease patients
Outcomes reported
The guideline synthesises evidence-based recommendations for the management of chronic coronary disease, including risk factor modification strategies such as dietary approaches for secondary prevention. It reports consensus guidance on clinical decision-making, pharmacological interventions, and lifestyle modifications including nutritional counselling.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.